Unspecified type of carcinoma in situ of unspecified breast
ICD-10 D05.90 is a billable code used to indicate a diagnosis of unspecified type of carcinoma in situ of unspecified breast.
Carcinoma in situ (CIS) of the breast refers to a group of abnormal cells that are found in the lining of the breast ducts or lobules. These cells have the potential to become invasive cancer but are currently non-invasive. The term 'unspecified type' indicates that the specific subtype of carcinoma in situ, such as ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS), has not been determined. Patients diagnosed with D05.90 may undergo regular surveillance protocols, including mammograms and clinical breast exams, to monitor for any changes that could indicate progression to invasive cancer. The risk of progression from carcinoma in situ to invasive breast cancer varies, with DCIS having a higher risk compared to LCIS. Factors influencing progression include tumor size, grade, and the presence of necrosis. Early detection and treatment are crucial in managing this condition, as timely intervention can significantly reduce the risk of developing invasive breast cancer.
Detailed pathology reports, treatment plans, and follow-up notes are essential for accurate coding.
Patients presenting with abnormal mammograms, biopsy results indicating carcinoma in situ, and those undergoing treatment or surveillance.
Oncologists must ensure that the type of carcinoma in situ is clearly documented to avoid coding errors.
Radiology reports must clearly indicate findings related to carcinoma in situ and any recommendations for follow-up imaging.
Imaging studies performed for patients with a known diagnosis of carcinoma in situ or those with suspicious findings.
Radiologists should provide comprehensive reports that correlate imaging findings with clinical history.
Used when a biopsy is performed to confirm a diagnosis of carcinoma in situ.
Pathology report confirming carcinoma in situ must be included.
Oncologists should ensure that the excision is documented as part of the treatment plan.
Carcinoma in situ refers to abnormal cells that are confined to their original location and have not invaded surrounding tissues. It is considered a non-invasive form of cancer.
Treatment options for carcinoma in situ may include surgery, radiation therapy, and close monitoring. The choice of treatment depends on the specific type and characteristics of the carcinoma.
